Table 1.
Clinical and laboratory characteristics of SLE patients.
| Symptoms | Number of patients | (%) |
|
| ||
|---|---|---|
| Total | 41 | 100% |
| Age (years) | ||
| Mean (range) | 40.5 (19–73) | — |
| Sex (male/female) | 3/38 | 7%/93% |
| Active/inactive | 19/22 | 46%/54% |
| Arthritis | 34 | 83% |
| Skin symptoms | 32 | 78% |
| Reticuloendothelial system involvement | 23 | 56% |
| Renal disorder (kreatinine > 1.3 mg/dL) | 4 | 40% |
| Neurologic symptoms | 27 | 66% |
| Antinuclear antibodies titer > 160 | 38 | 93% |
| dsDNA antibodies | 6 | 15% |
| Anemia (Hb < 12 g/dL) | 18 | 44% |
| Leukopenia (WBC < 3.5 × 109/L) | 14 | 34% |
| Thrombocytopenia (platelets < 150 × 109/L) | 12 | 29% |
| C reactive protein (> 5.99 mg/L) | 4 | 10% |
| Raised ESR (> 25 mm/h) | 20 | 49% |
| C 3 < 0.9 | 12 | 29% |
| C 4 < 0.1 | 5 | 12% |
| Immunosuppressive treatment with steroid and/or cytotoxic | 25 | 61% |
| agents during the study | ||